ESPyOC is a simple, cost-effective, and non-invasive chairside test that provides immediate results for patients with suspicious lesions. Using a patent-pending biomarker approach, ESPyOC demonstrated 99% sensitivity and 85% specificity for oral cancer detection in over 120 patients and accurately detected 79% of precancerous lesions.

concept development, Industrial design, integration, and prototyping.